Long-term exposure to anticholinergic and sedative medications and cognitive and physical function in later life.

07:00 EST 21st January 2019 | BioPortfolio

Summary of "Long-term exposure to anticholinergic and sedative medications and cognitive and physical function in later life."

Anticholinergic and sedative medications are frequently prescribed to older individuals. These medications are associated with short-term cognitive and physical impairment, but less is known about long-term associations. We therefore examined over twenty years whether cumulative exposure to these medications was related to poorer cognitive and physical functioning.


Journal Details

This article was published in the following journal.

Name: The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X


DeepDyve research library

PubMed Articles [25307 Associated PubMed Articles listed on BioPortfolio]

Anticholinergic exposure and cognitive decline in older adults: Effect of anticholinergic exposure definitions in a 3-year analysis of the Multidomain Alzheimer Preventive Trial (MAPT) study.

To assess the association between anticholinergic (atropinic) burden and cognitive decline in older adults over 3 years.

A Novel Research Method for Determining Sedative Exposure in Critically Ill Patients.

Although potent sedative and opioid drugs are some of the most commonly used medications to manage pain, anxiety, and discomfort in critically ill patients, conducting clinical trials where sedative a...

Anticholinergic Drug Induced Cognitive and Physical Impairment: Results from the InCHIANTI Study.

The aims of this study were to evaluate the relationship between anticholinergic drug burden (ACB) cognitive impairment, physical frailty and cognitive frailty, and determine if ACB is predictive of t...

Long-term effects of compulsory schooling on physical, mental and cognitive ageing: a natural experiment.

Longer schooling is associated with better physical, mental and cognitive functioning, but there is controversy as to whether these associations are causal. We examine the long-term health impact of a...

The relationship between polypharmacy and trajectories of cognitive decline in people with dementia: A large representative cohort study.

Polypharmacy, defined through the number of medications prescribed, has been linked to a range of adverse health outcomes in people with dementia. It is however unclear whether a numerical threshold o...

Clinical Trials [18366 Associated Clinical Trials listed on BioPortfolio]

Longitudinal Analysis of Drug Burden Index

Anticholinergic and sedative drugs are frequently prescribed to older people, despite their negative impact on older people's physical and cognitive function. To estimate the cumulative ex...

Anticholinergic Burden - Treatment Optimization

There is increasing evidence that medications with anticholinergic effects may adversely affect cognitive function. Older adults are particularly sensitive to anticholinergic effects becau...

MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care

This will be the first large cohort study to define the epidemiology of and identify modifiable risk factors for long-term CI and functional deficits of ICU survivors. We will measure the...

Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery

This study investigates the association of preoperative anticholinergic medication exposure with healthcare resource utilization in a population-based sample of older patients enrolled in ...

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

The purpose of this study is to assess the effects of caffeine reduction/elimination on urinary symptoms in women with overactive bladders and compare this therapeutic approach to antichol...

Medical and Biotech [MESH] Definitions

Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).

A long-acting, non-sedative antihistaminic used in the treatment of seasonal allergic rhinitis, asthma, allergic conjunctivitis, and chronic idiopathic urticaria. The drug is well tolerated and has no anticholinergic side effects.

Health insurance to provide full or partial coverage for long-term home care services or for long-term nursing care provided in a residential facility such as a nursing home.

Experiments designed to determine the potential toxic effects of a long-term exposure to a chemical or chemicals.

A plasticizer used in most plastics and found in water, air, soil, plants and animals. It may have some adverse effects with long-term exposure.

Quick Search


DeepDyve research library

Searches Linking to this Article